HERLEV, Denmark, Nov. 11, 2024 /PRNewswire/ — Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a Letter of Support (LoS) from the U.S. Food and Drug Administration (FDA). For the past thirty years, Nordic Bioscience has continuously…